News & events

On 20 October, PIONEER joined a group of 29 stakeholders in welcoming the European Commission’s proposal on the European Health Data Space. The stakeholders, which include medical professional and research organisations, patient representatives, industry associations and data collaborations strongly...

Catch up on all the developments related to the PIONEER patient-related outcome measures and core outcome set working groups. Find the latest publications as well as two in-depht interviews with the PIONEER members tackling these important research areas here!

PIONEER: The International Network of Excellence for Big Data in Prostate Cancer announces that consortium partner SAS has deployed their latest advanced analytics capabilities in the central PIONEER Big Data Platform for Prostate Cancer. In partnership with the Center...

Multiple diagnostic & prognostic biomarkers are available to improve prostate cancer diagnosis and prognosis. However, knowledge on which diagnostic and prognostic biomarkers can be used to select patients for a specific treatment remains unclear. Developed by a multidisciplinary team...

PIONEER: The International Network of Excellence for Big Data in Prostate Cancer announces the release of their core outcome sets for localised, locally advanced, metastatic and non-metastatic castration resistant prostate cancer. The PIONEER Core Outcome Sets (COS) for Localised,...

Prostate Cancer (PCa) is characterised by a relatively long natural history, where a substantial proportion of PCa patients die from causes other than the disease itself. As a result of this there is an increasing awareness of the importance...